nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adherence to guidelines-recommended diagnostic testing was associated with overall survival in patients with diffuse large B-cell lymphoma after rituximab-based treatment: an observational cohort study
|
Yang, Fei |
|
|
149 |
7 |
p. 3691-3700 |
artikel |
2 |
Advantages of organ-sparing treatment approaches in metastatic kidney cancer
|
Vitruk, Iurii |
|
|
149 |
7 |
p. 3131-3137 |
artikel |
3 |
Age-dependent genomic characteristics and their impact on immunotherapy in lung adenocarcinoma
|
Li, Peng |
|
|
149 |
7 |
p. 2997-3007 |
artikel |
4 |
Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of glioma
|
Liao, Gang |
|
|
149 |
7 |
p. 3485-3494 |
artikel |
5 |
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma
|
He, Pengcheng |
|
|
149 |
7 |
p. 2757-2769 |
artikel |
6 |
A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade
|
Ozaniak, Andrej |
|
|
149 |
7 |
p. 3789-3801 |
artikel |
7 |
Anticancer bioactivity of zerumbone on pediatric rhabdomyosarcoma cells
|
Urla, Cristian |
|
|
149 |
7 |
p. 3313-3323 |
artikel |
8 |
Anti-PD-1 for the treatment of advanced cutaneous squamous cell carcinoma in elderly patients: a French multicenter retrospective survey
|
Samaran, Quentin |
|
|
149 |
7 |
p. 3549-3562 |
artikel |
9 |
Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells
|
Zhang, Xin |
|
|
149 |
7 |
p. 3871-3883 |
artikel |
10 |
Association between oral cavity cancer and metabolic syndrome
|
Choi, Gang Won |
|
|
149 |
7 |
p. 4005-4013 |
artikel |
11 |
Association between secondhand smoke and cancers in adults in the US population
|
Zhang, Zhongmian |
|
|
149 |
7 |
p. 3447-3455 |
artikel |
12 |
Association of birth weight with cancer risk: a dose–response meta-analysis and Mendelian randomization study
|
Chen, Chao |
|
|
149 |
7 |
p. 3925-3935 |
artikel |
13 |
AURKA is a prognostic potential therapeutic target in skin cutaneous melanoma modulating the tumor microenvironment, apoptosis, and hypoxia
|
Long, ShengYong |
|
|
149 |
7 |
p. 3089-3107 |
artikel |
14 |
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
|
Huemer, Florian |
|
|
149 |
7 |
p. 3051-3064 |
artikel |
15 |
Breast cancer patient-reported outcomes on level 1 and level 2 oncoplastic procedures using BREAST-Q®
|
Pinto, C. A. |
|
|
149 |
7 |
p. 3229-3241 |
artikel |
16 |
Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030
|
Fang, Yuan |
|
|
149 |
7 |
p. 3209-3218 |
artikel |
17 |
Cancer patients’ experiences and preferences when receiving bad news: a qualitative study
|
Krieger, Theresia |
|
|
149 |
7 |
p. 3859-3870 |
artikel |
18 |
Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial–mesenchymal transition through the Wnt/β-catenin signaling pathway
|
Feng, PanFeng |
|
|
149 |
7 |
p. 3587-3598 |
artikel |
19 |
Characterization of PDL1 enhanced siRNA/albumin liposome for effective therapeutic function in lung cancer
|
Zhang, Liming |
|
|
149 |
7 |
p. 3835-3846 |
artikel |
20 |
Circulating circular RNA hsa_circ_0023179 acts as a diagnostic biomarker for non-small-cell lung cancer detection
|
Zhang, Qi |
|
|
149 |
7 |
p. 3649-3660 |
artikel |
21 |
Classification prediction of early pulmonary nodes based on weighted gene correlation network analysis and machine learning
|
Li, Guang |
|
|
149 |
7 |
p. 3915-3924 |
artikel |
22 |
Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia
|
Mai, Huirong |
|
|
149 |
7 |
p. 3259-3266 |
artikel |
23 |
Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience
|
Park, Meerim |
|
|
149 |
7 |
p. 3109-3119 |
artikel |
24 |
Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effects
|
Liu, Cynthia |
|
|
149 |
7 |
p. 3965-3976 |
artikel |
25 |
Clinical, laboratory, pathological, and radiological characteristics and prognosis of patients with pulmonary salivary gland-type tumors
|
Zhang, Yuan |
|
|
149 |
7 |
p. 4025-4039 |
artikel |
26 |
Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer
|
Yamada, Yuki |
|
|
149 |
7 |
p. 3277-3285 |
artikel |
27 |
Clinical value and influencing factors of establishing stomach cancer organoids by endoscopic biopsy
|
Li, Jie |
|
|
149 |
7 |
p. 3803-3810 |
artikel |
28 |
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents
|
Escudero-Vilaplana, Vicente |
|
|
149 |
7 |
p. 2855-2882 |
artikel |
29 |
Contribution of TLR4 to colorectal tumor microenvironment, etiology and prognosis
|
Crame, Elise E. |
|
|
149 |
7 |
p. 3009-3021 |
artikel |
30 |
CRISPR/Cas9 mediated knocking out of OPN gene enhances radiosensitivity in MDA-MB-231 breast cancer cell line
|
Ghanbarnasab Behbahani, Rahil |
|
|
149 |
7 |
p. 4117-4130 |
artikel |
31 |
Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype
|
Angius, Andrea |
|
|
149 |
7 |
p. 3951-3963 |
artikel |
32 |
Decision-making by cancer patients and the role of a counselling facility for complementary and alternative medicine: a cohort study
|
Hack, Vanessa |
|
|
149 |
7 |
p. 2903-2913 |
artikel |
33 |
Detailed functional results after bladder-preserving surgery and high-dose-rate brachytherapy in pediatric bladder/prostate rhabdomyosarcoma
|
Ellerkamp, Verena |
|
|
149 |
7 |
p. 3161-3170 |
artikel |
34 |
Differential role of chronic liver diseases on the incidence of cancer: a longitudinal analysis among 248,224 outpatients in Germany
|
Loosen, Sven H. |
|
|
149 |
7 |
p. 3081-3087 |
artikel |
35 |
Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development
|
Fu, Jiantao |
|
|
149 |
7 |
p. 4047-4061 |
artikel |
36 |
Distinct cellular immune profiles in lung adenocarcinoma manifesting as pure ground glass opacity versus solid nodules
|
Qu, Rirong |
|
|
149 |
7 |
p. 3775-3788 |
artikel |
37 |
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry
|
Valcarcel, Sena |
|
|
149 |
7 |
p. 4077-4089 |
artikel |
38 |
Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
|
Takeuchi, Eiji |
|
|
149 |
7 |
p. 3139-3147 |
artikel |
39 |
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors
|
Mellgard, George |
|
|
149 |
7 |
p. 2833-2841 |
artikel |
40 |
Effects and mechanisms of GSG2 in esophageal cancer progression
|
Geng, Chong |
|
|
149 |
7 |
p. 3409-3421 |
artikel |
41 |
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients
|
Arayici, Mehmet Emin |
|
|
149 |
7 |
p. 2915-2928 |
artikel |
42 |
Efficacy and safety of EGFR‑TKIs plus Shenqi Fuzheng injection for non-small cell lung cancer patients with EGFR-sensitive mutations
|
Wang, Jia-li |
|
|
149 |
7 |
p. 3895-3903 |
artikel |
43 |
Efficacy and safety of immune checkpoint inhibitors in post-TKI NSCLC patients harboring EGFR mutations
|
Sun, Si |
|
|
149 |
7 |
p. 2937-2949 |
artikel |
44 |
Epidemiological and clinicopathological analysis of basal cell carcinoma in Egyptian population: a 5-year retrospective multicenter study
|
El-Khalawany, Mohamed |
|
|
149 |
7 |
p. 3121-3129 |
artikel |
45 |
Evaluation of different imaging modalities for axillary lymph node staging in breast cancer patients to provide a personalized and optimized therapy algorithm
|
Diessner, Joachim |
|
|
149 |
7 |
p. 3457-3467 |
artikel |
46 |
Fibroblast activation protein in the tumor microenvironment predicts outcomes of PD-1 blockade therapy in advanced non-small cell lung cancer
|
Zhao, Yan |
|
|
149 |
7 |
p. 3469-3483 |
artikel |
47 |
FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy
|
Davern, Maria |
|
|
149 |
7 |
p. 3753-3774 |
artikel |
48 |
Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis
|
Shi, Shuangshuang |
|
|
149 |
7 |
p. 3349-3360 |
artikel |
49 |
Heterogeneous expression of ACE2, TMPRSS2, and FURIN at single-cell resolution in advanced non-small cell lung cancer
|
Liu, Zeyu |
|
|
149 |
7 |
p. 3563-3573 |
artikel |
50 |
Histomorphological and molecular genetic characterization of different intratumoral regions and matched metastatic lymph nodes of colorectal cancer with heterogenous mismatch repair protein expression
|
Zhang, Jing |
|
|
149 |
7 |
p. 3423-3434 |
artikel |
51 |
History of keratinocyte carcinoma and survival after a second primary malignancy: the Moffitt Cancer Center patient experience
|
Amorrortu, Rossybelle P. |
|
|
149 |
7 |
p. 3607-3621 |
artikel |
52 |
How can counselling by family physicians on nutrition and physical activity be improved: trends from a survey in Germany
|
Boesenecker, S. J. |
|
|
149 |
7 |
p. 3335-3347 |
artikel |
53 |
IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma
|
Struckmeier, Ann-Kristin |
|
|
149 |
7 |
p. 3623-3635 |
artikel |
54 |
Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus
|
Zapała, Łukasz |
|
|
149 |
7 |
p. 4131-4139 |
artikel |
55 |
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis
|
Martins-Branco, Diogo |
|
|
149 |
7 |
p. 3075-3080 |
artikel |
56 |
Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study
|
Wang, Song-Yau |
|
|
149 |
7 |
p. 3739-3752 |
artikel |
57 |
Improved preoperative risk stratification in endometrial carcinoma patients: external validation of the ENDORISK Bayesian network model in a large population-based case series
|
Grube, Marcel |
|
|
149 |
7 |
p. 3361-3369 |
artikel |
58 |
Incidence and associated factors for incidental prostate cancer among patients who underwent surgery for benign prostatic hyperplasia: first report from Somalia
|
Mohamed, Abdikarim Hussein |
|
|
149 |
7 |
p. 4041-4046 |
artikel |
59 |
Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany
|
Nachtsheim, Lisa |
|
|
149 |
7 |
p. 3811-3821 |
artikel |
60 |
Incidence of asymptomatic COVID-19 positivity in cancer patients and effects on therapy
|
Liu, Lisa |
|
|
149 |
7 |
p. 3243-3247 |
artikel |
61 |
Increased morbidity evaluated on hospital contacts and prescriptions among 100,834 Danish breast cancer survivors
|
Fredslund, Stine Overvad |
|
|
149 |
7 |
p. 2823-2831 |
artikel |
62 |
In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcoma
|
Sobczuk, Paweł |
|
|
149 |
7 |
p. 2771-2782 |
artikel |
63 |
Interferon-γ predicts the treatment efficiency of immune checkpoint inhibitors in cancer patients
|
Liu, Jing |
|
|
149 |
7 |
p. 3043-3050 |
artikel |
64 |
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study
|
Roessler, Daniel |
|
|
149 |
7 |
p. 3065-3073 |
artikel |
65 |
KNTC1 as a putative tumor oncogene in pancreatic cancer
|
Liu, Ling |
|
|
149 |
7 |
p. 3023-3031 |
artikel |
66 |
Longitudinal associations of sedentary behavior and physical activity with body composition in colorectal cancer survivors up to 2 years post treatment
|
Kenkhuis, Marlou-Floor |
|
|
149 |
7 |
p. 4063-4075 |
artikel |
67 |
Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer
|
Bakker, Andrea |
|
|
149 |
7 |
p. 3721-3728 |
artikel |
68 |
m6A regulator-mediated methylation modification highlights immune infiltration patterns for predicting risk in hepatocellular carcinoma
|
Zhou, Dongkai |
|
|
149 |
7 |
p. 3661-3680 |
artikel |
69 |
m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma
|
Zhang, Tao |
|
|
149 |
7 |
p. 2805-2822 |
artikel |
70 |
MDFNet: application of multimodal fusion method based on skin image and clinical data to skin cancer classification
|
Chen, Qian |
|
|
149 |
7 |
p. 3287-3299 |
artikel |
71 |
Mesalamine and cholestyramine for immune checkpoint inhibitor-mediated diarrhea and colitis
|
Hollander, Barbara |
|
|
149 |
7 |
p. 3637-3648 |
artikel |
72 |
MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study
|
Wang, Na |
|
|
149 |
7 |
p. 3219-3228 |
artikel |
73 |
Modified DEP regimen as induction therapy for lymphoma-associated hemophagocytic lymphohistiocytosis: a prospective, multicenter study
|
Pi, Yubo |
|
|
149 |
7 |
p. 3033-3041 |
artikel |
74 |
Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study
|
Xu, Chao |
|
|
149 |
7 |
p. 4091-4099 |
artikel |
75 |
Nodal and osseous oligometastatic prostate cancer: a cohort including the introduction of PSMA-PET/CT-guided stereotactic and hypofractionated radiotherapy with elective nodal therapy
|
Gawish, Ahmed |
|
|
149 |
7 |
p. 3937-3949 |
artikel |
76 |
Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR
|
Matsuzawa, Reiko |
|
|
149 |
7 |
p. 3885-3893 |
artikel |
77 |
Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients
|
Higashiyama, Ryoko Inaba |
|
|
149 |
7 |
p. 3185-3191 |
artikel |
78 |
Nurses’ knowledge of chemotherapy-induced neutropenia and its management: a cross-sectional survey
|
Al Qadire, Mohammad |
|
|
149 |
7 |
p. 2893-2901 |
artikel |
79 |
Nutrition and physical activity in cancer patients: a survey on their information sources
|
Boesenecker, Sebastian Josef |
|
|
149 |
7 |
p. 3823-3833 |
artikel |
80 |
Optical coherence tomography and convolutional neural networks can differentiate colorectal liver metastases from liver parenchyma ex vivo
|
Amygdalos, Iakovos |
|
|
149 |
7 |
p. 3575-3586 |
artikel |
81 |
Pan-cancer analysis of tumor mutation burden sensitive tumors reveals tumor-specific subtypes and hub genes related to immune infiltration
|
Wu, Huan |
|
|
149 |
7 |
p. 2793-2804 |
artikel |
82 |
Pancreatic cancer among solid organ transplant recipients in the United States
|
Tanaka, Tomohiro |
|
|
149 |
7 |
p. 3325-3333 |
artikel |
83 |
PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer
|
Russo, Giorgio Ivan |
|
|
149 |
7 |
p. 3681-3690 |
artikel |
84 |
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma
|
Lazaridis, Lazaros |
|
|
149 |
7 |
p. 3513-3526 |
artikel |
85 |
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden
|
Leccisotti, Lucia |
|
|
149 |
7 |
p. 2783-2791 |
artikel |
86 |
Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model
|
Eini, Leila |
|
|
149 |
7 |
p. 4101-4116 |
artikel |
87 |
Prognosis of different extrathoracic metastasis patterns in patients with M1c lung adenocarcinoma receiving immunotherapy
|
Hu, Fang |
|
|
149 |
7 |
p. 3171-3184 |
artikel |
88 |
Quality of life in Tunisian colorectal cancer patients: a cross-sectional study
|
Belaid, Imtinene |
|
|
149 |
7 |
p. 2735-2742 |
artikel |
89 |
Radiomics based on enhanced CT for differentiating between pulmonary tuberculosis and pulmonary adenocarcinoma presenting as solid nodules or masses
|
Zhao, Wenjing |
|
|
149 |
7 |
p. 3395-3408 |
artikel |
90 |
Rare benign liver tumors that require differentiation from hepatocellular carcinoma: focus on diagnosis and treatment
|
Luo, Laihui |
|
|
149 |
7 |
p. 2843-2854 |
artikel |
91 |
Real world data on IO-based therapy for metastatic renal cell carcinoma
|
Stühler, Viktoria |
|
|
149 |
7 |
p. 3249-3258 |
artikel |
92 |
Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China
|
Wen, Qing |
|
|
149 |
7 |
p. 3989-4003 |
artikel |
93 |
Repeat hepatectomy for pediatric recurrent chemotherapy-resistant hepatoblastoma: a report of 18 cases
|
Li, Xiaoran |
|
|
149 |
7 |
p. 4015-4023 |
artikel |
94 |
Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study
|
Oliinyk, Dmytro |
|
|
149 |
7 |
p. 3527-3547 |
artikel |
95 |
Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemic
|
Ksienski, Doran |
|
|
149 |
7 |
p. 2951-2961 |
artikel |
96 |
Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes
|
Lu, Chang |
|
|
149 |
7 |
p. 2987-2995 |
artikel |
97 |
Seroprevalence study prior and post vaccination in cancer patients in principality of Andorra (COVONCO study)
|
Royo-Cebrecos, Cristina |
|
|
149 |
7 |
p. 2883-2892 |
artikel |
98 |
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer
|
Inoue, Yusuke |
|
|
149 |
7 |
p. 2963-2974 |
artikel |
99 |
Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort
|
Neuberger, Manuel |
|
|
149 |
7 |
p. 3371-3381 |
artikel |
100 |
Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer
|
Liu, Han-Yuan |
|
|
149 |
7 |
p. 2743-2756 |
artikel |
101 |
Technique to match mesorectal lymph nodes imaging findings to histopathology: node-by-node comparison
|
Zhuang, Zixuan |
|
|
149 |
7 |
p. 3905-3914 |
artikel |
102 |
The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation
|
Cambui, Raylane Adrielle Gonçalves |
|
|
149 |
7 |
p. 3729-3738 |
artikel |
103 |
The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study
|
Guven, Deniz Can |
|
|
149 |
7 |
p. 3599-3606 |
artikel |
104 |
The crosstalk between lung cancer cells and platelets promotes tumor angiogenesis in vivo and in vitro
|
Li, Baikun |
|
|
149 |
7 |
p. 3495-3511 |
artikel |
105 |
The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition
|
Bauer, Arthur |
|
|
149 |
7 |
p. 3193-3208 |
artikel |
106 |
The OUTREACH study: oncologists of German university hospitals in rotation on a palliative care unit—evaluation of attitude and competence in palliative care and hospice
|
Biersching, T. |
|
|
149 |
7 |
p. 2929-2936 |
artikel |
107 |
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
|
Borgmann, Mara |
|
|
149 |
7 |
p. 3383-3393 |
artikel |
108 |
The prognostic role of the immunohistochemical expression of S100 in meningiomas
|
Behling, Felix |
|
|
149 |
7 |
p. 2975-2985 |
artikel |
109 |
The role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sex
|
Wahli, Murielle N. |
|
|
149 |
7 |
p. 3847-3858 |
artikel |
110 |
The role of microRNA-30c in targeting interleukin 6, as an inflammatory cytokine, in the mesenchymal stem cell: a therapeutic approach in colorectal cancer
|
Mahjoor, Mohamad |
|
|
149 |
7 |
p. 3149-3160 |
artikel |
111 |
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
|
Flörsch, Benedikt |
|
|
149 |
7 |
p. 3267-3276 |
artikel |
112 |
Triple negative breast cancer: approved treatment options and their mechanisms of action
|
Mandapati, Aditya |
|
|
149 |
7 |
p. 3701-3719 |
artikel |
113 |
Uncertainty-aware dynamic integration for multi-omics classification of tumors
|
Du, Ling |
|
|
149 |
7 |
p. 3301-3312 |
artikel |
114 |
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study
|
Avancini, Alice |
|
|
149 |
7 |
p. 3435-3445 |
artikel |
115 |
Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-β and enhances chemoradiotherapy resistance
|
Liu, Yu |
|
|
149 |
7 |
p. 3977-3988 |
artikel |